Sana Bio’s $150 Million IPO Expected to Provide Market Valuation of $10 Billion
The Pharma Data
JANUARY 17, 2021
But that number doesn’t quite reflect the company’s likely market valuation , which is expected to be between $9 billion and $12 billion. Based in Seattle, Washington, Sana focuses on in vivo and ex vivo cell engineering platforms to develop therapies for cancer, diabetes, cardiovascular disease, CNS disorders, and genetic diseases.
Let's personalize your content